Journey in reverse: TTP from bedside to blood bank to bench
Tóm tắt
Từ khóa
Tài liệu tham khảo
Marcus A, 1992, Hemolytic uremic syndrome and thrombotic thromboctyopenic purpura, 19
Moschcowitz E, 1924, Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease, Proc NY Pathol Soc, 24, 21
Baehr G, 1936, An acute febrile anemia and thrombocytopenic purpura with diffuse platelet thrombosis of capillaries and arterioles, Trans Assoc Am Phys, 65, 45
Harkness D, 1981, Hazard of platelet transfusion in thrombotic thrombocytopenic purpura, J Am Med Assoc, 246, 1931, 10.1001/jama.1981.03320170043028
Bukowski RM, 1976, Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura, Semin Hematol, 13, 219
Bukowski RM, 1982, Thrombotic thrombocytopenic purpura: a review, Progr Hemost Thromb, 6, 287
Schulman I, 1960, Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency, Blood, 16, 943, 10.1182/blood.V16.1.943.943
Moake JL, 1985, Effects of fresh‐frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 65, 1232, 10.1182/blood.V65.5.1232.1232
Frangos JA, 1989, Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells, Am J Physiol, 256, H1635
Moake J, 1994, Solvent/detergent‐treated plasma suppresses shear‐induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura, Blood, 84, 490, 10.1182/blood.V84.2.490.490
Furlan M, 1997, Deficient activity of von Willegrand factor‐cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 89, 3097, 10.1182/blood.V89.9.3097
Furlan M, 1998, Acquired deficiency of von Willebrand factor‐cleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91, 2839, 10.1182/blood.V91.8.2839.2839_2839_2846
Rabadi SJ, 1982, Mitomycin‐induced hemolytic uremic syndrome: case presentation and review of literature, Cancer Treat Rep, 66, 1244
Gottschall JL, 1991, Quinine‐induced immune thrombocytopenia associated with hemolytic‐uremic syndrome: a new clinical entity, Blood, 77, 306, 10.1182/blood.V77.2.306.306
Byrnes JJ, 1986, Thrombotic thrombocytopenic purpura and the hemolytic‐uremic syndrome: evolving concepts of pathogenesis and therapy, Clinics Haematol, 15, 413, 10.1016/S0308-2261(18)30024-9
van der Plas RM, 1999, von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation‐associated thrombotic thrombocytopenic purpura, Blood, 93, 3798, 10.1182/blood.V93.11.3798
Ruggeri ZM, 2000, Developing basic and clinical research on von Willebrand factor and von Willebrand disease, Thromb Haemost, 84, 147, 10.1055/s-0037-1613989
Tsai HM, 1996, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its confirmation and requires calcium ion, Blood, 87, 4235, 10.1182/blood.V87.10.4235.bloodjournal87104235
Bork P, 1993, The CUB domain ‐ a widespread module in developmentally regulated proteins, J Mo Biol, 231, 530
Moake JL, 1989, Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and hemolytic‐uremic syndrome, Am J Med, 87, 9N
Oleksowicz L, 1999, Deficient activity of von Willebrand's factor‐cleaving protease in patients with disseminated malignancies, Cancer Res, 59, 2244
Abassi E, 2004, Correlation of ADAMTS‐13 activity with response to plasma exchange in patients diagnosed with thrombotic thrombocytopenic purpura, Blood, 104, 242a
Thompson CE, 1992, Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic, Blood, 80, 1890, 10.1182/blood.V80.8.1890.bloodjournal8081890
Kremer Hovinga JA, 2004, Splenectomy in relapsing and plasma‐refractory acquired thrombotic thrombocytopenic purpura, Haematologica, 89, 320
Gordon LI, 1987, Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy, Semin Hematol, 24, 194